The growth in research and development in 2020 was largely driven by new oncology drugs, new funding, and strategic investments – which all speak to the resilience and strength of the global biopharmaceutical industry.

This webinar follows the release of a new IQVIA Institute report on Global Trends in R&D: Overview through 2020 and is intended to generate meaningful discussion among a multi-stakeholder panel around timely topics related to R&D trends in 2020.

Speakers and panelists

The webinar will be moderated by Murray Aitken, Executive Director, the IQVIA Institute for Human Data Science. Speakers are:

  • Amitabh Chandra, Professor of Business Administration at Harvard Business School and Director of Health Policy Research at Harvard Kennedy School of Government
  • Cartier Esham, EVP, Emerging Companies & SVP, Science and Regulatory Affairs, Biotechnology Innovation Organization (BIO)
  • Ken Getz, Director of the Tufts Center for the Study of Drug Development

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.